Diet and risk of inflammatory bowel disease

Digestive and Liver Disease

Volumn 44, Issue 3, 2012, Pages 185-194

  Andersen, Vibeke ^a,b   Olsen, Anja ^c   Carbonnel, Franck ^d   Tjønneland, Anne ^c   Vogel, Ulla ^e,f  

^a VIBORG HOSPITAL   (Denmark)

^b Medical Department   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^f TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Animal protein; Crohn's disease; Fish; Food; Intestinal inflammation; Meat; Ulcerative colitis

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM SILICATE; ANTIBIOTIC AGENT; ASCORBIC ACID; CAROTENE; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RETINOL; SUGAR; TITANIUM DIOXIDE; VITAMIN D;

APPENDECTOMY; COCHRANE LIBRARY; COHORT ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; ENERGY; ENTERITIS; EUROPE; FISH; FRUIT; HUMAN; INTESTINE FLORA; MACRONUTRIENT; MEAT; MEDLINE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DIET; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VEGETABLE;

COLITIS, ULCERATIVE; CROHN DISEASE; DIET; DIETARY PROTEINS; FATTY ACIDS, UNSATURATED; FOOD; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84856562701     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.10.001     Document Type: Review

References (113)

1. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
2. Kalischuk L.D., Buret A.G. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?. Am J Physiol Gastrointest Liver Physiol 2010, 298:G1-G9.
3. Kappelman M.D., Rifas-Shiman S.L., Porter C.Q., et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008, 135:1907-1913.
4. Odes S., Vardi H., Friger M., et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006, 131:719-728.
5. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521.
6. Anderson C.A., Massey D.C., Barrett J.C., et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009, 136:523-529.
7. Franke A., McGovern D.P., Barrett J.C., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
8. Fukata M., Abreu M.T. Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol 2009, 9:680-687.
9. Fukata M., Vamadevan A.S., Abreu M.T. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009, 21:242-253.
10. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
11. Bosscher D., Breynaert A., Pieters L., et al. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J Physiol Pharmacol 2009, 60(Suppl. 6):5-11.
12. Ferguson L.R. Nutrigenomics and inflammatory bowel diseases. Expert Rev Clin Immunol 2010, 6:573-583.
13. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
14. Dore J., Corthier G. The human intestinal microbiota. Gastroenterol Clin Biol 2010, 34(Suppl. 1):S7-S15.
15. Flint H.J., Duncan S.H., Scott K.P., et al. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 2007, 9:1101-1111.
16. Lakatos P.L. Environmental factors affecting inflammatory bowel disease: have we made progress?. Dig Dis 2009, 27:215-225.
17. Buchanan E., Gaunt W.W., Cardigan T., et al. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009, 30:501-507.
18. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol 2006, 12:6102-6108.
19. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
20. Economou M., Pappas G. New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008, 14:709-720.
21. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996, 39:690-697.
22. Armitage E.L., Aldhous M.C., Anderson N., et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004, 127:1051-1057.
23. Kappelman M.D., Rifas-Shiman S.L., Kleinman K., et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007, 5:1424-1429.
24. Nerich V., Monnet E., Etienne A., et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006, 12:218-226.
25. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2009, 9:A372-A378.
26. Noble C.L., Arnott I.D. What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S22-S23.
27. Halfvarson J., Jess T., Magnuson A., et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006, 12:925-933.
28. Halme L., Paavola-Sakki P., Turunen U., et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006, 12:3668-3672.
29. Marshall J.K. Are there epidemiological differences between Crohn's disease and ulcerative colitis?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S1.
30. Mahid S.S., Minor K.S., Soto R.E., et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.
31. Gearry R.B., Richardson A.K., Frampton C.M., et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010, 25:325-333.
32. Frisch M., Pedersen B.V., Andersson R.E. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. Br Med J 2009, 338:b716. 10.1136/bmj.b716.
33. Hviid A., Svanstrom H., Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011, 60:49-54.
34. Kaplan G.G., Jackson T., Sands B.E., et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008, 103:2925-2931.
35. Gradel K.O., Nielsen H.L., Schonheyder H.C., et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009, 137:495-501.
36. Jess T., Simonsen J., Nielsen N.M., et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 2011, 60:318-324.
37. Marchesi J.R. Prokaryotic and eukaryotic diversity of the human gut. Adv Appl Microbiol 2010, 72:43-62.
38. Marteau P. Bacterial flora in inflammatory bowel disease. Dig Dis 2009, 27(Suppl. 1):99-103.
39. Nell S., Suerbaum S., Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010, 8:564-577.
40. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010, 107:12204-12209.
41. Weinstock J.V., Elliott D.E. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009, 15:128-133.
42. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007, 1:CD000542.
43. Inoue N., Tamura K., Kinouchi Y., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002, 123:86-91.
44. Shoda R., Matsueda K., Yamato S., et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996, 63:741-745.
45. Hakansson A., Branning C., Adawi D., et al. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scand J Gastroenterol 2009, 44:1213-1225.
46. Kitahora T., Utsunomiya T., Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995, 30(Suppl. 8):5-8.
47. Sonnenberg A. Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease. Digestion 1988, 41:161-171.
48. Maconi G., Ardizzone S., Cucino C., et al. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010, 16:4297-4304.
49. Sakamoto N., Kono S., Wakai K., et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005, 11:154-163.
50. Amre D.K., D'Souza S., Morgan K., et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102:2016-2025.
51. D'Souza S., Levy E., Mack D., et al. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008, 14:367-373.
52. Hart A.R., Luben R., Olsen A., et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008, 77:57-64.
53. Jantchou P., Morois S., Clavel-Chapelon F., et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010, 105:2195-2201.
54. Tjonneland A., Overvad K., Bergmann M.M., et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009, 58:1606-1611.
55. John S., Luben R., Shrestha S.S., et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2010, 22:602-606.
56. Jowett S.L., Seal C.J., Pearce M.S., et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004, 53:1479-1484.
57. Luhrs H., Gerke T., Muller J.G., et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002, 37:458-466.
58. Pajak B., Orzechowski A., Gajkowska B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv Med Sci 2007, 52:83-88.
59. Tedelind S., Westberg F., Kjerrulf M., et al. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007, 13:2826-2832.
60. Damaskos D., Kolios G. Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol 2008, 65:453-467.
61. Roberts C.L., Keita A.V., Duncan S.H., et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010, 59:1331-1339.
62. Meddings J. The significance of the gut barrier in disease. Gut 2008, 57:438-440.
63. Adlercreutz H. Lignans and human health. Crit Rev Clin Lab Sci 2007, 44:483-525.
64. Suzuki T., Hara H. Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem 2010.
65. Eberlein M., Scheibner K.A., Black K.E., et al. Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm (Lond) 2008, 5:20.
66. Schrenk D. Dietary fiber, low-molecular-weight food constituents and colo-rectal inflammation in animal models-a review. Mol Nutr Food Res 2009, 53:1281-1288.
67. Yamamoto T., Nakahigashi M., Saniabadi A.R. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther 2009, 30:99-112.
68. World Cancer Research Fund/American Institute for Cancer Research FNPAatoCaGPA, Washington, DC; 2007. http://www.dietandcancerreport.org/.
69. Gonzalez C.A. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2006, 9:124-126.
70. Holt E.M., Steffen L.M., Moran A., et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc 2009, 109:414-421.
71. Gibson P.R., Shepherd S.J. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease The FODMAP hypothesis. Aliment Pharmacol Ther 2005, 21:1399-1409.
72. A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995, 30(Suppl. 8):9-12.
73. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010, 39:365-379. [Table].
74. Liu P.T., Stenger S., Tang D.H., et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179:2060-2063.
75. Liu N., Kaplan A.T., Low J., et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 2009, 80:398-406.
76. Schwalfenberg G.K. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011, 55:96-108.
77. Schauber J., Rieger D., Weiler F., et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006, 18:615-621.
78. Wehkamp J., Schmid M., Stange E.F. Defensins other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007, 23:370-378.
79. Mora J.R., von Andrian U.H. Differentiation and homing of IgA-secreting cells. Mucosal Immunol 2008, 1:96-109.
80. Xu L., Kitani A., Stuelten C., et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 2010, 33:313-325.
81. Hugot J.P., Alberti C., Berrebi D., et al. Crohn's disease: the cold chain hypothesis. Lancet 2003, 362:2012-2015.
82. Jorgensen S.P., Agnholt J., Glerup H., et al. Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010, 32:377-383.
83. Ekbom A., Montgomery S.M. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol 2004, 18:497-508.
84. Lomer M.C., Hutchinson C., Volkert S., et al. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr 2004, 92:947-955.
85. Lomer M.C., Thompson R.P., Powell J.J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002, 61:123-130.
86. Lomer M.C., Grainger S.L., Ede R., et al. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur J Gastroenterol Hepatol 2005, 17:377-384.
87. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Aliment Pharmacol Ther 2002, 16:1997-2015.
88. Wang K., Wan Y.J. Nuclear receptors and inflammatory diseases. Exp Biol Med (Maywood) 2008, 233:496-506.
89. Langmann T., Moehle C., Mauerer R., et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004, 127:26-40.
90. Ferrer R., Moreno J.J. Role of eicosanoids on intestinal epithelial homeostasis. Biochem Pharmacol 2010, 80:431-438.
91. Joosen A.M., Kuhnle G.G., Aspinall S.M., et al. Effect of processed and red meat on endogenous nitrosation and DNA damage. Carcinogenesis 2009, 30:1402-1407.
92. Schepens M.A., Vink C., Schonewille A.J., et al. Dietary heme adversely affects experimental colitis in rats, despite heat-shock protein induction. Nutrition 2011, 27:590-597.
93. Doherty C.P. Host-pathogen interactions: the role of iron. J Nutr 2007, 137:1341-1344.
94. Aamodt G., Bukholm G., Jahnsen J., et al. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol 2008, 168:1065-1072.
95. Andersen V., Ernst A., Christensen J., et al. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohn's disease in a Danish case-control study. BMC Med Genet 2010, 11:82.
96. Santarelli R.L., Pierre F., Corpet D.E. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 2008, 60:131-144.
97. Nishida T., Miwa H., Shigematsu A., et al. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 1987, 28:1002-1007.
98. Knoch B., Barnett M.P., McNabb W.C., et al. Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Mol Nutr Food Res 2010, 54(Suppl. 1):S62-S74.
99. Harris W.S., Mozaffarian D., Rimm E., et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009, 119:902-907.
100. de Silva P.S., Olsen A., Christensen J., et al. An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. Gastroenterology 2010, 139:1912-1917.
101. EU Food Safety - From Farm to Fork, Residues of veterinary medicinal products - control and monitoring, 2011. http://ec.europa.eu/food/food/chemicalsafety/residues/control_en.htm.
102. Joensen A.M., Schmidt E.B., Dethlefsen C., et al. Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome-a cohort study. Br J Nutr 2010, 103:602-607.
103. Andersen V., Nimmo E., Krarup H.B., et al. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Inflamm Bowel Dis 2011, 17:937-946.
104. Walker D.G., Williams H.R., Kane S.P., et al. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am J Gastroenterol 2011, 106:1281-1289.
105. Ernst A., Jacobsen B., Ostergaard M., et al. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population. Scand J Gastroenterol 2007, 42:1445-1451.
106. van der L.K., Boor P.P., Houwing-Duistermaat J.J., et al. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. Eur J Gastroenterol Hepatol 2007, 19:449-459.
107. Ostergaard M., Ernst A., Labouriau R., et al. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population. Scand J Gastroenterol 2009, 44:65-73.
108. Annese V., Valvano M.R., Palmieri O., et al. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol 2006, 12:3636-3644.
109. Ma J., Betts N.M., Hampl J.S. Clustering of lifestyle behaviors: the relationship between cigarette smoking, alcohol consumption, and dietary intake. Am J Health Promot 2000, 15:107-117.
110. Riordan A.M., Ruxton C.H., Hunter J.O. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998, 52:229-238.
111. World Resources Institute. Earth Trends, The environmental information portal, 2009. http://earthtrends.wri.org/searchable_db/index.php?theme=8&variable_ID=193&action=select_countries.
112. Hill B.A. The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
113. Frangos C.C., Frangos C.C. Inflammatory bowel disease: reviewing an old study under a new perspective. Gut 2007, 56:1638-1639.